Risk stratification and medical therapy of pulmonary arterial hypertension
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of multiple drugs interfering with the endothelin, nitric oxide and prostacyclin pathways. The recent progress observed in medical therapy of PAH is not, therefore, related to the discovery of new pathways, but to the development of new strategies for combination therapy and on escalation of treatments based on systematic assessment of clinical response. The current treatment strategy is based on the severity of the newly diagnosed PAH patient as assessed by a multiparametric risk stratification approach. Clinical, exercise, right ventricular function and haemodynamic parameters are combined to define a low-, intermediate- or high-risk status according to the expected 1-year mortality. The current treatment algorithm provides the most appropriate initial strategy, including monotherapy, or double or triple combination therapy. Further treatment escalation is required in case low-risk status is not achieved in planned follow-up assessments. Lung transplantation may be required in most advanced cases on maximal medical therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 Time-course of completed randomised controlled trials (RCTs) in pulmonary arterial hypertension (PAH) (n=41) according to treatment strategy. SSc: systemic sclerosis; IPAH: idiopathic PAH. Reproduced and modified from [70] with permission.](https://figures.cochat.ai/paper-figures/44281cb9913845f29b53a42c8e3258e5/risk-stratification-and-medical-therapy-of-pulmonary-arterial-hypertension-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other high-risk profiles include familial PAH, PVOD, CTD-PAH, CTD-PAH associated with concomitant ILD, rapidly progressive disease despite therapy, and development of hemoptysis.(282, 291–293)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In particular, the 2018 World Symposium on Pulmonary Hypertension strongly recommends serial parametric risk assessment.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“The 2018 World Symposium on Pulmonary Hypertension states that the ultimate goal of therapy for patients with PAH is to achieve a low-risk status, assessed either by REVEAL or the ESC/ERS model.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationHaemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationBosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Self-citationBarst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Self-citationInhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Self-citationBenza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Self-citationChannick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,534
Self-citation
Research works printed but not linked: 2
- Benza, 2018, Comparison of three assessment strategies as predictors of one-year survival in US pulmonary arterial hypertension (PAH) patients, Am J Respir Crit Care Med, 197, A7649
- Galiè, 2014, AMBITION: a randomised, multicenter study of first-line ambrisentan and tadalafil combination therapy in subjects with pulmonary arterial hypertension (PAH), Eur Respir J, 44, 2916
Cited by
Items 201–300 of 897
Lu, G., Du, R., Liu, Y., Zhang, S., Li, J., & Pei, J. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s429535 · Cited by 21
Kong, D., Liu, J., Lu, J., Zeng, C. C., Chen, H., Duan, Z., Yu, K., Zheng, X., Zou, P., Zhou, L., et al. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319916 · Cited by 21
Martín, M. V., Cabezas, J. M. M., Nieto, S. H., Nuche, J., Albarrán, A., Delgado, J. F., Alonso, S., Sarnago, F., Arribas, F., & Subías, P. E. (2020) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.29194 · Cited by 21
Olschewski, H. (2021) · Diagnostics · doi:10.3390/diagnostics11020311 · Cited by 21
Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertension
Naranjo, M., Mercurio, V., Hassan, H. J., Alturaif, N., Cuomo, A., Attanasio, U., Diab, N., Sahetya, S. K., Mukherjee, M., Hsu, S., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00002-2022 · Cited by 21
Bajwa, E. K., Cislak, D., Palcza, J. S., Feng, H.-P., Messina, E. J., Reynders, T., Denef, J., Vasile, C., Lai, E., & Stoch, S. A. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.107065 · Cited by 21
Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension
Zelt, J. G. E., Hossain, A., Sun, L. Y., Mehta, S., Chandy, G., Davies, R. A., Contreras-Domínguez, V., Dunne, R., Doyle-Cox, C., Wells, G. A., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.026 · Cited by 21
Mulvaney, E. P., Reid, H. M., Bialešová, L., Mendes‐Ferreira, P., Adão, R., Brás‐Silva, C., & Kinsella, B. T. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173658 · Cited by 21
Sahay, S., Visovatti, S., Tonelli, A. R., Villasmil, N., Austin, E. D., Badagliacca, R., Berger, R. M. F., Boucly, A., Chen, Y., Church, C., et al. (2025) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2025.04.015 · Cited by 20
Self-citationPereira, M. C., Moreira, M. M., & Mendes, F. A. R. (2022) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20210483 · Cited by 20
Langleben, D., Orfanos, S. E., Fox, B. D., Messas, N., Giovinazzo, M., & Catravas, J. D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154568 · Cited by 20
Ahmed, A., Ahmed, S., Kempe, D., & Rådegran, G. (2023) · European Heart Journal Open · doi:10.1093/ehjopen/oead012 · Cited by 20
Swisher, J. W., & Weaver, E. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s321025 · Cited by 20
Emerging biologics for the treatment of pulmonary arterial hypertension
Hye, T., Hossain, M. R., Saha, D., Foyez, T., & Ahsan, F. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2199351 · Cited by 20
Fadilah, A., Putri, V. Y. S., Puling, I. M. D. R., & Willyanto, S. E. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1422327 · Cited by 20
Tsuboya, N., Sawada, H., Mitani, Y., Oshita, H., Ohya, K., Takeoka, M., Kabwe, J. C., Miyasaka, Y., Ito, H., Yodoya, N., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae244 · Cited by 20
Liu, L., Li, C., Cai, J., Kong, R., Wang, Y., Wang, Y., Li, S., Zhan, J., & Liu, Y. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1515961 · Cited by 20
Rosenkranz, S., Diller, G., Dumitrescu, D., Ewert, R., Ghofrani, H. A., Grünig, E., Halank, M., Held, M., Kaemmerer, H. M., Klose, H. F. E., et al. (2019) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0918-3772 · Cited by 20
Self-citationStuder, S. M., HULL, M. L., Pruett, J., Elliott, C., Tsang, Y., & Drake, W. (2019) · Pulmonary Therapy · doi:10.1007/s41030-019-00106-4 · Cited by 20
Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension
Prins, K. W., Kalra, R., Rose, L., Assad, T. R., Archer, S. L., Bajaj, N. S., Weir, Ε. K., Prisco, S. Z., PRITZKER, M. R., Lutsey, P. L., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015221 · Cited by 20
3D in vitro Model of Vascular Medial Thickening in Pulmonary Arterial Hypertension
Morii, C., Tanaka, H. Y., Izushi, Y., Nakao, N., Yamamoto, M., Matsubara, H., Kano, M. R., & Ogawa, A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00482 · Cited by 20
Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension
Xanthouli, P., Theobald, V., Benjamin, N., Marra, A. M., D'Agostino, A. G., Egenlauf, B., Shaukat, M., Ding, C., Cittadini, A., Bossone, E., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01884-9 · Cited by 20
Self-citationNathan, S. D., Fernandes, P., Psotka, M. A., Vitulo, P., Piccari, L., Antoniou, K., Nikkho, S. M., & Stockbridge, N. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12178 · Cited by 20
Sinha, M., Zabini, D., Guntur, D., Nagaraj, C., Enyedi, P., Olschewski, H., Kuebler, W. M., & Olschewski, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108249 · Cited by 19
Hemodynamic indices in pulmonary hypertension: a narrative review
Manek, G., Gupta, M., Chhabria, M., Bajaj, D., Agrawal, A., & Tonelli, A. R. (2022) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-22-244 · Cited by 19
Diagnosis and management of pulmonary arterial hypertension
Cullivan, S., Higgins, M., & Gaine, S. (2022) · Breathe · doi:10.1183/20734735.0168-2022 · Cited by 19
Xie, F., Quan, R., Zhang, G., Tian, H., Chen, Y., Yu, Z., Zhang, C., Liu, Y., Zhu, X., Wu, W., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2023.02.1494 · Cited by 19
Gomberg‐Maitland, M., Badesch, D. B., Gibbs, J. S. R., Grünig, E., Hoeper, M. M., Humbert, M. J. C., Kopeć, G., McLaughlin, V. V., Meyer, G. M. B., Olsson, K. M., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.11.037 · Cited by 19
Self-citationArgula, R. G., Ward, C., & Feghali‐Bostwick, C. A. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s219024 · Cited by 19
Longitudinal Changes in Risk Status in Pulmonary Arterial Hypertension
Bouzina, H., Rådegran, G., Butler, O., Hesselstrand, R., Hjalmarsson, C., Holl, K., Jansson, K., Klok, R. M., Söderberg, S., & Kjellström, B. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13162 · Cited by 19
Potts shunt as an effective palliation for patients with end stage pulmonary arterial hypertension
Bobhate, P., Mohanty, S. R., Tailor, K. B., Kadam, S., Karande, T., Bhavsar, K., Kattana, H. B. R., Rao, S., & Kulkarni, S. M. (2021) · Indian Heart Journal · doi:10.1016/j.ihj.2021.01.007 · Cited by 19
Pulmonary Hypertension Complicating Pregnancy
Krishnan, S., Fricke, E. M., Cordoba, M. I., Chalifoux, L. A., & Girgis, R. E. (2021) · Current Pulmonology Reports · doi:10.1007/s13665-021-00275-1 · Cited by 19
Utilization of risk assessment tools in management of PAH: A PAH provider survey
Sahay, S., Balasubramanian, V. P., Memon, H. A., Poms, A. D., Bossone, E., Highland, K., Kay, D., Levine, D. J., Mullin, C. J., Melendres-Groves, L. D., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12057 · Cited by 19
Qin, J., Wang, G., & Han, D. H. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101466 · Cited by 19
Sotatercept for pulmonary arterial hypertension: something old and something new
Rubin, L. J., & Naeije, R. (2023) · European Respiratory Journal · doi:10.1183/13993003.01972-2022 · Cited by 19
Mamzer, A., Waligóra, M., Kopeć, G., Ptaszyńska‐Kopczyńska, K., Kurzyna, M., Darocha, S., Florczyk, M., Mroczek, E., Mularek‐Kubzdela, T., Smukowska-Gorynia, A., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148423 · Cited by 18
Ma, R., Cheng, L., Song, Y., Sun, Y., Gui, W., Deng, Y. L., Xie, C., & Liu, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.940784 · Cited by 18
Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review
Lokhorst, C., van der Werf, S., Berger, R. M. F., & Douwes, J. M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1035453 · Cited by 18
Liu, P., Gao, S., Li, Z., Pan, S., Luo, G., & Ji, Z. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175725 · Cited by 18
Honda, Y., Kosugi, K., Fuchikami, C., Kuramoto, K., Numakura, Y., & Kuwano, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240692 · Cited by 18
Lichtblau, M., Berlier, C., Saxer, S., Carta, A. F., Mayer, L. C., Groth, A., Bader, P. R., Schneider, S., Furian, M., Schwarz, E. I., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.681473 · Cited by 18
Carbon Monoxide Diffusion Capacity as a Severity Marker in Pulmonary Hypertension
Diamanti, E., Karava, V., Yerly, P., & Aubert, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010132 · Cited by 18
Salvador, M. L., Padial, L. R., Abánades, C. S., Cruz‐Utrilla, A., Mir, J. A. B., López‐Meseguer, M., Segovia, J., Samper, G. J., Vich, I. B., Subías, P. E., et al. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13468 · Cited by 18
Lai, J., Zhao, J., Li, K., Qin, X., Wang, H., Tian, Z., Wang, Q., Li, M., Guo, X., Liu, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.872795 · Cited by 18
An algorithm to identify cases of pulmonary arterial hypertension from the electronic medical record
Schuler, K., Hemnes, A. R., Annis, J. S., Farber‐Eger, E. H., Lowery, B. D., Halliday, S. J., & Brittain, E. L. (2022) · Respiratory Research · doi:10.1186/s12931-022-02055-0 · Cited by 18
Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography
Mercurio, V., Hassan, H. J., Naranjo, M., Cuomo, A., Mazurek, J. A., Forfia, P. R., Balasubramanian, A., Simpson, C. E., Damico, R. L., Kolb, T. M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144034 · Cited by 18
Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertension
Ranasinghe, A. D. C. U., & Schwarz, M. A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115245 · Cited by 18
The Myths and Realities of Portopulmonary Hypertension
DuBrock, H. M., & Krowka, M. J. (2020) · Hepatology · doi:10.1002/hep.31415 · Cited by 18
Grünig, E., Eichstaedt, C. A., Seeger, R., & Benjamin, N. (2020) · Diagnostics · doi:10.3390/diagnostics10121110 · Cited by 17
Self-citationStubbe, B., Opitz, C. F., Halank, M., Habedank, D., & Ewert, R. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106336 · Cited by 17
Wißmüller, M., Xanthouli, P., Benjamin, N., Grünig, E., Richter, M. J., Gall, H. J., Ghofrani, H. A., Herkenrath, S. D., Skowasch, D., Pizarro, C., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13804 · Cited by 17
Self-citationLin, Y., Pang, L., Huang, S., Shen, J., Wu, W., Tang, F., Su, W., Zhu, X., Sun, J., Quan, R., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.908215 · Cited by 17
Ye, P., Jiang, X., Qian, W., & Zhang, J. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07458-9 · Cited by 17
Systemic sclerosis-associated pulmonary arterial hypertension in children
Apitz, C., & Girschick, H. J. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-901 · Cited by 17
Zhang, M., Zeng, Q., Zhou, S. Y., Zhu, G., Xu, Y., Gao, R., Su, W., & Wang, R. (2023) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2023.2183963 · Cited by 16
Pulmonary hypertension in hereditary hemorrhagic telangiectasia: A clinical review
Mathavan, A., Mathavan, A., Reddy, R., Jones, K., Eagan, C., Alnuaimat, H., & Ataya, A. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12301 · Cited by 16
Tomita, S., Nakanishi, N., Ogata, T., Higuchi, Y., Sakamoto, A., Tsuji, Y., Suga, T., & Matoba, S. (2024) · Communications Biology · doi:10.1038/s42003-023-05693-2 · Cited by 16
Liu, Y., He, C., Zhong, Q., Shi, X., Li, H., Fu, G., Guo, L., Zhao, C., Tian, L., Li, X., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s493047 · Cited by 16
Long‐term results of the DelIVery for Pulmonary Arterial Hypertension trial
Gomberg‐Maitland, M., Bourge, R. C., Shapiro, S., Tarver, J., Zwicke, D. L., Feldman, J. P., Chakinala, M. M., Frantz, R. P., Torres, F., Bag, R., et al. (2019) · Pulmonary Circulation · doi:10.1177/2045894019878615 · Cited by 16
Self-citationOverview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension
Kenny, M., Clarke, M. M., & Pogue, K. T. (2020) · Journal of Pharmacy Practice · doi:10.1177/0897190020961291 · Cited by 16
The evolving treatment landscape of pulmonary arterial hypertension
Gale, S. (2021) · The American Journal of Managed Care · doi:10.37765/ajmc.2021.88610 · Cited by 16
Vicaire, H., Pavec, J. L., Mercier, O. M., Montani, D., Boucly, A., Roche, A., Pradère, P., Dauriat, G., Feuillet, S., Pichon, J., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.06.001 · Cited by 16
Recent Advances in the Treatment of Pulmonary Arterial Hypertension
Otani, N., Tomoe, T., Kawabe, A., Sugiyama, T., Horie, Y., Sugimura, H., Yasu, T., & Nakamoto, T. (2022) · Pharmaceuticals · doi:10.3390/ph15101277 · Cited by 16
Gillmeyer, K. R., Rinne, S. T., Qian, S. X., Maron, B. A., Johnson, S. W., Klings, E. S., & Wiener, R. S. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12171 · Cited by 16
Wu, W., Chen, A., Lin, S., Wang, Q., Lian, G., Luo, L., & Xie, L. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02275-6 · Cited by 16
Remote exercise testing in pulmonary hypertension (PHRET)
Stubbs, H., Lua, S., Ingram, J., Jani, B., Brewis, M. J., Church, C., & Johnson, M. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12325 · Cited by 16
CASCINO, T. M., & McLaughlin, V. V. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202107-1625ed · Cited by 16
Self-citationRefined risk stratification in pulmonary arterial hypertension and timing of lung transplantation
Olsson, K. M., Richter, M. J., Kamp, J. C., Gall, H. J., Ghofrani, H. A., Fuge, J., Ewert, R., & Hoeper, M. M. (2022) · European Respiratory Journal · doi:10.1183/13993003.03087-2021 · Cited by 16
Health Care Disparities in Pulmonary Arterial Hypertension
Bernardo, R. J., & Pérez, V. D. J. (2023) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2023.03.010 · Cited by 15
Pan, J.-R., Wu, Q., Chen, S., Wang, H., & Wang, Q. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03435-5 · Cited by 15
Diao, W., Liu, G., Shi, C., Jiang, Y., Li, H., Meng, J., Shi, Y., Chang, M., & Liu, X. (2022) · Cell Transplantation · doi:10.1177/09636897221081479 · Cited by 15
Barbagelata, L., Masson, W. M., Bluro, I. M., Lobo, M., Iglesias, D., & Molinero, G. (2022) · Advances in respiratory medicine · doi:10.5603/arm.a2022.0030 · Cited by 15
Clinical application of risk assessment in PAH: Expert center APRN recommendations
Wilson, M. A., Keeley, J. H., Kingman, M. S., McDevitt, S., Brewer, J., Rogers, F., Hill, W., Rideman, Z., & Broderick, M. J. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12106 · Cited by 15
Farmakis, I. T., Vrana, E., Mouratoglou, S., Zafeiropoulos, S., Zanos, S. P., & Giannakoulas, G. A. (2022) · ERJ Open Research · doi:10.1183/23120541.00313-2022 · Cited by 15
Kelly, N. J., & Chan, S. Y. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2311378 · Cited by 15
Sex- and Gender-Related Aspects in Pulmonary Hypertension
D'Agostino, A. G., Guindani, P., Scaglione, G., Vincenzo, A. D., Tamascelli, S., Spaggiari, R., Salzano, A., D’Amuri, A., Marra, A. M., Pilote, L., et al. (2022) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.09.002 · Cited by 15
2022 Update of indications and contraindications for lung transplantation in France
Pavec, J. L., Pison, C. M., Hirschi, S., Bunel, V., Mordant, P., Brugière, O., Guen, M. L., Olland, A., Coiffard, B., Renaud-Picard, B., et al. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100981 · Cited by 15
Chandrasekara, S. D., Lau, E., Anderson, J., Collins, N. J., Cordina, R., Corrigan, C., Dwyer, N., Feenstra, J., Horrigan, M., KEOGH, A. M., et al. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.09.005 · Cited by 15
Li, J., Yang, Z.-Y., Wang, S., Yuan, P., Zhao, Q., Gong, S., Qiu, H., Luo, C., Li, H., Zhang, R., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.977110 · Cited by 15
Hanthazi, A., Jespers, P., Vegh, G., Dubois, C., Hubesch, G., Springael, J., Dewachter, L., & Entee, K. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00926 · Cited by 15
Ocupaçao da época romana na cidade do Porto: ponto de situaçao e perspectivas de pesquisa
Silva, A. M. S. P. (2010) · Gallaecia: revista de arqueoloxía e antigüidade · Cited by 15
A novel approach to perioperative risk assessment for patients with pulmonary hypertension
Hassan, H. J., Housten, T., Balasubramanian, A., Simpson, C. E., Damico, R. L., Mathai, S. C., Hassoun, P. M., Steppan, J., Leary, P. J., & Kolb, T. M. (2021) · ERJ Open Research · doi:10.1183/23120541.00257-2021 · Cited by 15
Takeyasu, R., Tamura, Y., Abe, K., Goda, A., Satoh, T., Suda, R., Tanabe, N., Tsujino, I., Yamazaki, T., & Tatsumi, K. (2020) · Circulation Reports · doi:10.1253/circrep.cr-20-0014 · Cited by 14
Self-citationIncident pulmonary arterial hypertension associated with Bosutinib
Yo, S. W., Thenganatt, J., Lipton, J. H., & Granton, J. T. (2020) · Pulmonary Circulation · doi:10.1177/2045894020936913 · Cited by 14
Bermudez, C. A., Crespo, M. M., Shlobin, O. A., Cantu, E., Mazurek, J. A., Levine, D. J., Gutsche, J. T., Kanwar, M. K., Dellgren, G., Bush, E. L., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.016 · Cited by 14
Li, L., Yin, M., Hu, L., Tian, X., He, X., Zhao, C., Li, Y., Li, Q., & Li, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.691405 · Cited by 14
Jutras-Beaudoin, N., Toro, V., Lajoie, A. C., Breuils‐Bonnet, S., Paulin, R., & Potus, F. (2021) · CJC Open · doi:10.1016/j.cjco.2021.11.010 · Cited by 14
Tang, Y., Huo, X., Liu, J., Tang, Y., Zhang, M., Xie, W., Zheng, Z., He, J., & Lian, J. (2022) · Cardiovascular Therapeutics · doi:10.1155/2022/4382999 · Cited by 14
Lago‐Docampo, M., Solarat, C., Méndez-Martínez, L., Baloira, A., & Valverde, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.823133 · Cited by 14
The feasibility and value of assessing patient‐reported outcomes in pulmonary arterial hypertension
DuBrock, H. M., Reddy, Y. N. V., Durst, L. A., Schroeder, D. R., Park, G. S. H., Cajigas, H. R., Kane, G. C., Kushwaha, S. S., McCully, R. B., Murphy, J. G., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12143 · Cited by 14
Self-citationManagement of Pulmonary Arterial Hypertension in the ICU
Torbic, H. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019838110 · Cited by 14
Paeonol protects mitochondrial injury and prevents pulmonary vascular remodeling in hypoxia
Wang, D., Du, Y., Xu, H., Pan, H., & Wang, R. (2019) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2019.103252 · Cited by 14
Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension
Chandel, A., Verster, A. S. W., Rahim, H., Khangoora, V. S., Nathan, S. D., Ahmad, K., Aryal, S., Bagnola, A. J., SINGHAL, A. L., Brown, A. W., et al. (2021) · Pulmonary Circulation · doi:10.1177/20458940211012366 · Cited by 14
Selexipag for the treatment of pulmonary arterial hypertension
Genecand, L., Wacker, J., Beghetti, M., & Lador, F. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1866990 · Cited by 14
Pulmonary arterial hypertension registries: past, present and into the future
Weatherald, J. C., Reis, A., Sitbon, O., & Humbert, M. J. C. (2019) · European Respiratory Review · doi:10.1183/16000617.0128-2019 · Cited by 14
The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg?
Rhodes, C. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.02350-2020 · Cited by 14
Göransson, C., Vejlstrup, N. G., & Carlsen, J. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12097 · Cited by 13
Kolaitis, N. A., Barnes, H., Levine, D. J., Castillo, H., Arcasoy, S. M., Bacchetta, M. D., Benvenuto, L. J., Rosenzweig, E. B., Cevasco, M., Demarest, C. T., et al. (2025) · Pulmonary Circulation · doi:10.1002/pul2.70088 · Cited by 13
Pulmonary arterial hypertension: guidelines and unmet clinical needs
Giuggioli, D., Bruni, C., Cacciapaglia, F., Dardi, F., Cata, A. D., Papa, N. D., Iannone, F., Lunardi, C., Maglione, W., Molinaro, F., et al. (2021) · Reumatismo · doi:10.4081/reumatismo.2020.1310 · Cited by 13
Benza, R. L., Boucly, A., Farber, H. W., Frost, A., Ghofrani, H. A., Hoeper, M. M., Lambelet, M., Rahner, C., Bansilal, S., Nikkho, S. M., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.10.013 · Cited by 13
Metadata
- Authors
- Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., & McLaughlin, V. V.
- Affiliations
- University of Bologna (IT)
- Harvard University (US)
- Mayo Clinic (US)
- University Hospital Heidelberg (DE)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Tufts University (US)
- Houston Methodist (US)
- International University of Health and Welfare (JP)
- University of Michigan (US)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801889
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351343
- OpenAlex
- W2904385559
- Cited by
- 819
- References
- 88
- Citations by year
- 2026: 32 · 2025: 46 · 2024: 101 · 2023: 108 · 2022: 174 · 2021: 169 · 2020: 128 · 2019: 58
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- Funders
- Japan Society for the Promotion of Science (18K08183)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- pulmonary arterial hypertension, risk stratification, medical therapy, combination therapy, treatment escalation, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, prostacyclin analogues, right ventricular function, exercise capacity, one-year mortality, lung transplantation, treatment algorithm
- MeSH terms
- Pulmonary Arterial Hypertension, Calcium Channel Blockers, Humans, Randomized Controlled Trials as Topic, Lung Transplantation, Practice Guidelines as Topic, Risk Assessment, Phosphodiesterase 5 Inhibitors, Endothelin Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.